Melanie H Jacobson1, Penelope P Howards1, Lyndsey A Darrow1,2,3, Juliana W Meadows4, James S Kesner4, Jessica B Spencer5, Metrecia L Terrell1, Michele Marcus1,2. 1. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 2. Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 3. School of Community Health Sciences, University of Nevada, Reno, NV, USA. 4. Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, OH, USA. 5. Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Emory University School of Medicine, Atlanta, GA, USA.
Abstract
BACKGROUND: Previous studies have reported that hyperthyroid and hypothyroid women experience menstrual irregularities more often compared with euthyroid women, but reasons for this are not well-understood and studies on thyroid hormones among euthyroid women are lacking. In a prospective cohort study of euthyroid women, this study characterised the relationship between thyroid hormone concentrations and prospectively collected menstrual function outcomes. METHODS: Between 2004-2014, 86 euthyroid premenopausal women not lactating or taking hormonal medications participated in a study measuring menstrual function. Serum thyroid hormones were measured before the menstrual function study began. Women then collected first morning urine voids and completed daily bleeding diaries every day for three cycles. Urinary oestrogen and progesterone metabolites (estrone 3-glucuronide (E1 3G) and pregnanediol 3-glucuronide (Pd3G)) and follicle-stimulating hormone were measured and adjusted for creatinine (Cr). RESULTS: Total thyroxine (T4 ) concentrations were positively associated with Pd3G and E1 3G. Women with higher (vs lower) T4 had greater luteal phase maximum Pd3G (Pd3G = 11.7 μg/mg Cr for women with high T4 vs Pd3G = 9.5 and 8.1 μg/mg Cr for women with medium and low T4 , respectively) and greater follicular phase maximum E1 3G (E1 3G = 41.7 ng/mg Cr for women with high T4 vs E1 3G = 34.3 and 33.7 ng/mg Cr for women with medium and low T4 , respectively). CONCLUSIONS: Circulating thyroid hormone concentrations were associated with subtle differences in menstrual cycle function outcomes, particularly sex steroid hormone levels in healthy women. Results contribute to the understanding of the relationship between thyroid function and the menstrual cycle, and may have implications for fertility and chronic disease.
BACKGROUND: Previous studies have reported that hyperthyroid and hypothyroidwomen experience menstrual irregularities more often compared with euthyroid women, but reasons for this are not well-understood and studies on thyroid hormones among euthyroid women are lacking. In a prospective cohort study of euthyroid women, this study characterised the relationship between thyroid hormone concentrations and prospectively collected menstrual function outcomes. METHODS: Between 2004-2014, 86 euthyroid premenopausal women not lactating or taking hormonal medications participated in a study measuring menstrual function. Serum thyroid hormones were measured before the menstrual function study began. Women then collected first morning urine voids and completed daily bleeding diaries every day for three cycles. Urinary oestrogen and progesterone metabolites (estrone 3-glucuronide (E1 3G) and pregnanediol 3-glucuronide (Pd3G)) and follicle-stimulating hormone were measured and adjusted for creatinine (Cr). RESULTS: Total thyroxine (T4 ) concentrations were positively associated with Pd3G and E1 3G. Women with higher (vs lower) T4 had greater luteal phase maximum Pd3G (Pd3G = 11.7 μg/mg Cr for women with high T4 vs Pd3G = 9.5 and 8.1 μg/mg Cr for women with medium and low T4 , respectively) and greater follicular phase maximum E1 3G (E1 3G = 41.7 ng/mg Cr for women with high T4 vs E1 3G = 34.3 and 33.7 ng/mg Cr for women with medium and low T4 , respectively). CONCLUSIONS: Circulating thyroid hormone concentrations were associated with subtle differences in menstrual cycle function outcomes, particularly sex steroid hormone levels in healthy women. Results contribute to the understanding of the relationship between thyroid function and the menstrual cycle, and may have implications for fertility and chronic disease.
Authors: Andrew S Rowland; Donna Day Baird; Stuart Long; Ganesa Wegienka; Siobán D Harlow; Michael Alavanja; Dale P Sandler Journal: Epidemiology Date: 2002-11 Impact factor: 4.822
Authors: G E Krassas; N Pontikides; T Kaltsas; P Papadopoulou; J Paunkovic; N Paunkovic; L H Duntas Journal: Clin Endocrinol (Oxf) Date: 1999-05 Impact factor: 3.478
Authors: Anne Marie Zaura Jukic; Clarice R Weinberg; Allen J Wilcox; D Robert McConnaughey; Paige Hornsby; Donna D Baird Journal: Am J Epidemiol Date: 2007-10-10 Impact factor: 4.897
Authors: Kristine E Lynch; Sunni L Mumford; Karen C Schliep; Brian W Whitcomb; Shvetha M Zarek; Anna Z Pollack; Elizabeth R Bertone-Johnson; Michelle Danaher; Jean Wactawski-Wende; Audrey J Gaskins; Enrique F Schisterman Journal: Fertil Steril Date: 2014-05-27 Impact factor: 7.329
Authors: Sarah W Curtis; Metrecia L Terrell; Melanie H Jacobson; Dawayland O Cobb; Victoria S Jiang; Michael F Neblett; Sabrina A Gerkowicz; Jessica B Spencer; M Elizabeth Marder; Dana Boyd Barr; Karen N Conneely; Alicia K Smith; Michele Marcus Journal: Environ Health Date: 2019-08-23 Impact factor: 5.984
Authors: Lorenzo Moroni; Fulvio Barbaro; Florian Caiment; Orla Coleman; Sabine Costagliola; Giusy Di Conza; Lisa Elviri; Stefan Giselbrecht; Christian Krause; Carlos Mota; Marta Nazzari; Stephen R Pennington; Annette Ringwald; Monica Sandri; Simon Thomas; James Waddington; Roberto Toni Journal: Int J Mol Sci Date: 2020-05-21 Impact factor: 5.923